A potentially disease-modifying therapy for osteoarthritis has reached a key milestone now that a U.S. patent has been issued for FX201, a gene-therapy product candidate based on work led by Baylor researchers.
The Gulf Coast Center for Precision Environmental Health (GC-CPEH) has received a P30 award, designating it as a Center of Excellence in environmental health sciences research from the National Institute of Environmental Health Sciences (NIEHS).
The Michael E. DeBakey M.D. Award for Excellence in Research recognizes outstanding members of the Baylor College of Medicine faculty for their published scientific contributions to clinical or basic science research.
Gliogene, a study that aims to identify hereditary links of glioma, a rare and deadly form of brain cancer, has begun recruiting families affected by the disease in order to identify genes that contribute to its onset and inform susceptibility.
Analyzing both the entire set of genes and all the proteins produced by colon cancer tissues from patient samples has revealed a more comprehensive view of the tumor that points at novel cancer biological mechanisms and possible new therapeutic strategies.